Literature DB >> 7381717

Effect of exercise on renal clearance of atenolol.

W D Mason, G Kochak, N Winer, I Cohen.   

Abstract

The effect of exercise on plasma atenolol was evaluated using a two-phase complete crossover study in 12 healthy volunteers. In one phase, the volunteers were subjected to physical exertion on a treadmill; in the other phase, they remained in a sitting or standing position. Following a single 100-mg atenolol dose, frequent blood samples and a complete urine collection were obtained over 24 hr. Plasma and urine atenolol levels were assayed by high-pressure liquid chromatography. Plasma atenolol was significantly (p less than 0.05) higher during the exercise phase of the study, and this result was associated with approximately an 8% decrease in the renal clearance of the drug, probably due to decreased renal blood flow during exercise.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381717     DOI: 10.1002/jps.2600690325

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Transdermal patch drug delivery interactions with exercise.

Authors:  Thomas L Lenz; Nicole Gillespie
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

Review 2.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

3.  Comparison of the effects of prizidilol and propranolol on renal haemodynamics at rest and during exercise.

Authors:  P L Malini; E Strocchi; E Ambrosioni
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

4.  Exercise-induced increments in plasma levels of propranolol and noradrenaline.

Authors:  G A Hurwitz; J G Webb; T Walle; S A Bai; H B Daniell; L Gourley; C Boyd Loadholt; T E Gaffney
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 5.  Measurement of the renal clearance of drugs.

Authors:  G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.

Authors:  H T Folgering; J F Borm; R H van Haaren
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

Review 7.  Potential interactions between exercise and drug therapy.

Authors:  Thomas L Lenz; Nancy J Lenz; Michele A Faulkner
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.